Drug maker Mylan to move to Nasdaq
Generic drug maker Mylan Inc. is moving its stock exchange listing to the Nasdaq market from the New York Stock Exchange, effective Dec. 29.
Generic drugmaker Mylan Inc. says Milan Puskar, who co-founded the company, retired as chairman of the board on Thursday.